keyword
https://read.qxmd.com/read/38656467/genetic-diversity-of-kpc-2-producing-klebsiella-pneumoniae-complex-from-aquatic-ecosystems
#1
JOURNAL ARTICLE
Rafael da Silva Rosa, João Pedro Rueda Furlan, Lucas David Rodrigues Dos Santos, Micaela Santana Ramos, Eduardo Angelino Savazzi, Eliana Guedes Stehling
During the COVID-19 pandemic, the occurrence of carbapenem-resistant Klebsiella pneumoniae increased in human clinical settings worldwide. Impacted by this increase, international high-risk clones harboring carbapenemase-encoding genes have been circulating in different sources, including the environment. The blaKPC gene is the most commonly disseminated carbapenemase-encoding gene worldwide, whose transmission is carried out by different mobile genetic elements. In this study, blaKPC-2 -positive Klebsiella pneumoniae complex strains were isolated from different anthropogenically affected aquatic ecosystems and characterized using phenotypic, molecular, and genomic methods...
April 24, 2024: World Journal of Microbiology & Biotechnology
https://read.qxmd.com/read/38656082/molecular-epidemiology-and-clinical-significance-of-carbapenemase-genes-among-carbapenem-resistant-acinetobacter-baumannii-isolates-in-southern-poland
#2
JOURNAL ARTICLE
Piotr A Serwacki, Dariusz A Hareza, Anna Kujawska, Anna Pałka, Estera Jachowicz-Matczak, Agata Rybka-Grymek, Wioletta Świątek-Kwapniewska, Iwona Pawłowska, Zofia Gniadek, Karolina Gutkowska, Mateusz Gajda, Jadwiga Wójkowska-Mach
INTRODUCTION: The complex interplay between Acinetobacter spp., patients, and the environment has made it increasingly difficult to optimally treat patients infected with Acinetobacter spp., mainly due to rising antimicrobial resistance and challenges with surveillance. OBJECTIVES: This study evaluated carbapenem-resistance Acinetobacter baumannii (CRAB) isolates to determine their resistance profiles and the presence of specific β-lactamase enzymes to inform the use of CRAB surveillance upon hospital admission and regional empiric antibiotic therapies...
April 23, 2024: Polish Archives of Internal Medicine
https://read.qxmd.com/read/38655285/molecular-mechanisms-of-tigecycline-resistance-among-enterobacterales
#3
REVIEW
Lukasz Korczak, Piotr Majewski, Dominika Iwaniuk, Pawel Sacha, Mariola Matulewicz, Piotr Wieczorek, Paulina Majewska, Anna Wieczorek, Piotr Radziwon, Elzbieta Tryniszewska
The global emergence of antimicrobial resistance to multiple antibiotics has recently become a significant concern. Gram-negative bacteria, known for their ability to acquire mobile genetic elements such as plasmids, represent one of the most hazardous microorganisms. This phenomenon poses a serious threat to public health. Notably, the significance of tigecycline, a member of the antibiotic group glycylcyclines and derivative of tetracyclines has increased. Tigecycline is one of the last-resort antimicrobial drugs used to treat complicated infections caused by multidrug-resistant (MDR) bacteria, extensively drug-resistant (XDR) bacteria or even pan-drug-resistant (PDR) bacteria...
2024: Frontiers in Cellular and Infection Microbiology
https://read.qxmd.com/read/38654215/a-challenging-case-of-carbapenem-resistant-klebsiella-pneumoniae-related-pyogenic-liver-abscess-with-capsular-polysaccharide-hyperproduction-a-case-report
#4
JOURNAL ARTICLE
Maryam Sohrabi, Neda Pirbonyeh, Mahvash Alizade Naini, Alireza Rasekhi, Abbas Ayoub, Zahra Hashemizadeh, Fereshteh Shahcheraghi
BACKGROUND: Carbapenem-resistant Klebsiella pneumoniae (CRKP) infections are a major public health problem, necessitating the administration of polymyxin E (colistin) as a last-line antibiotic. Meanwhile, the mortality rate associated with colistin-resistant K. pneumoniae infections is seriously increasing. On the other hand, importance of administration of carbapenems in promoting colistin resistance in K. pneumoniae is unknown. CASE PRESENTATION: We report a case of K...
April 23, 2024: BMC Infectious Diseases
https://read.qxmd.com/read/38651885/first-report-of-the-chromosomal-integration-of-carbapenemase-gene-bla-imp-19-in-acinetobacter-baumannii-ab322-the-legacy-of-integron-in-phage-plasmid
#5
JOURNAL ARTICLE
Yung-Luen Shih, Carl Jay Ballena Bregente, Pek Kee Chen, Tran Thi Dieu Thuy, Yu-Chen Chen, Han-Yueh Kuo, Hsu-Feng Lu, Cheng-Yen Kao
UNLABELLED: Integration of carbapenemase gene bla IMP into the chromosome of carbapenem-resistant Acinetobacter baumannii (CRAB) has not been reported. The aim of this study was to explore the genomic characteristics of CRAB AB322 isolated from a Taiwanese patient diagnosed with bacteremia in 2011, whose chromosome harbors bla IMP-19 . Disk diffusion and broth microdilution were employed to analyze the antimicrobial susceptibility of AB322 to 14 antimicrobials. Nanopore whole-genome sequencing platform was utilized for AB322 genome sequencing, and conjugation was further performed to investigate the transferability of bla IMP-19 to amikacin-resistant A...
April 23, 2024: Microbiology Spectrum
https://read.qxmd.com/read/38646622/evaluation-of-the-in-vitro-susceptibility-of-clinical-isolates-of-ndm-producing-klebsiella-pneumoniae-to-new-antibiotics-included-in-a-treatment-regimen-for-infections
#6
JOURNAL ARTICLE
Natalia Słabisz, Patrycja Leśnik, Jarosław Janc, Miłosz Fidut, Marzenna Bartoszewicz, Ruth Dudek-Wicher, Urszula Nawrot
BACKGROUND: Due to the growing resistance to routinely used antibiotics, the search for new antibiotics or their combinations with effective inhibitors against multidrug-resistant microorganisms is ongoing. In our study, we assessed the in vitro drug susceptibility of Klebsiella pneumoniae strains producing New Delhi metallo-β-lactamases (NDM) to antibiotics included in the Infectious Diseases Society of America (IDSA) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) recommendations...
2024: Frontiers in Microbiology
https://read.qxmd.com/read/38643223/detection-and-genomic-characterization-of-klebsiella-pneumoniae-and-escherichia-coli-harboring-tet-x4-in-black-kites-milvus-migrans-in-pakistan
#7
JOURNAL ARTICLE
Muhammad Hassan Mansoor, Xiaoyu Lu, Hanna Woksepp, Amna Sattar, Farwa Humak, Jabir Ali, Ruichao Li, Jonas Bonnedahl, Mashkoor Mohsin
The emergence of plasmid-mediated tigecycline resistance gene tet(X4) among clinically relevant bacteria has promoted significant concerns, as tigecycline is considered a last-resort drug against serious infections caused by multidrug-resistant bacteria. We herein focused on the isolation and molecular characterization of tet(X4)-positive Klebsiella pneumoniae (K. pneumoniae) and Escherichia coli (E. coli) in wild bird populations with anthropogenic interaction in Faisalabad, Pakistan. A total of 150 birds including black kites (Milvus migrans) and house crows (Corvus splendens) were screened for the presence of tigecycline resistance K...
April 20, 2024: Scientific Reports
https://read.qxmd.com/read/38639548/assessing-clinician-utilization-of-next-generation-antibiotics-against-resistant-gram-negative-infections-in-u-s-hospitals-a-retrospective-cohort-study
#8
JOURNAL ARTICLE
Jeffrey R Strich, Ahmed Mishuk, Guoqing Diao, Alexander Lawandi, Willy Li, Cumhur Y Demirkale, Ahmed Babiker, Alex Mancera, Bruce J Swihart, Morgan Walker, Christina Yek, Maniraj Neupane, Nathaniel De Jonge, Sarah Warner, Sameer S Kadri
BACKGROUND: The U.S. antibiotic market failure has threatened future innovation and supply. Understanding when and why clinicians underutilize recently approved gram-negative antibiotics might help prioritize the patient in future antibiotic development and potential market entry rewards. OBJECTIVE: To determine use patterns of recently U.S. Food and Drug Administration (FDA)-approved gram-negative antibiotics (ceftazidime-avibactam, ceftolozane-tazobactam, meropenem-vaborbactam, plazomicin, eravacycline, imipenem-relebactam-cilastatin, and cefiderocol) and identify factors associated with their preferential use (over traditional generic agents) in patients with gram-negative infections due to pathogens displaying difficult-to-treat resistance (DTR; that is, resistance to all first-line antibiotics)...
April 19, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38635685/in-vitro-activity-of-ceftazidime-avibactam-cefiderocol-meropenem-vaborbactam-and-imipenem-relebactam-against-clinical-strains-of-the-stenotrophomonas-maltophilia-complex
#9
JOURNAL ARTICLE
Braulio Josué Méndez-Sotelo, Mónica Delgado-Beltrán, Melissa Hernández-Durán, Claudia Adriana Colín-Castro, José Esquivel-Bautista, Sandra Angélica Ortega-Oliva, Jossue Ortiz-Álvarez, Rodolfo García-Contreras, Rafael Franco-Cendejas, Luis Esau Lopez Jacome
BACKGROUND: Infections caused by Stenotrophomonas maltophilia and related species are increasing worldwide. Unfortunately, treatment options are limited, whereas the antimicrobial resistance is increasing. METHODS: We included clinical isolates identified as S. maltophilia by VITEK 2 Compact. Ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam, cefiderocol, quinolones, and tetracycline family members were evaluated by broth microdilution method and compared with first-line treatment drugs...
2024: PloS One
https://read.qxmd.com/read/38628240/persistent-colonization-of-ciprofloxacin-resistant-and-extended-spectrum-%C3%AE-lactamase-esbl-producing-salmonella-enterica-serovar-kentucky-st198-in-a-patient-with-inflammatory-bowel-disease
#10
JOURNAL ARTICLE
Yue Jiang, Huilin Yang, Zhen-Yu Wang, Da-Chuan Lin, Xinan Jiao, Yunlong Hu, Jing Wang
OBJECTIVE: Salmonella enterica serovar Kentucky ST198 has emerged as a global threat to humans. In this study, we aimed to characterize the prolonged carriage of ciprofloxacin-resistant and extended-spectrum β-lactamase (ESBL)-producing S . Kentucky ST198 in a single patient with inflammatory bowel disease (IBD). METHODS: Three S . Kentucky strains were collected from a single patient with IBD on 11th January, 23rd January, and 8th February, 2022, respectively...
2024: Infection and Drug Resistance
https://read.qxmd.com/read/38619765/molecular-epidemiology-and-resistance-mechanisms-of-tigecycline-non-susceptible-acinetobacter-baumannii-isolated-from-a-tertiary-care-hospital-in-chongqing-china
#11
JOURNAL ARTICLE
Jiajia Liao, Jinzhu Huang, Peiwen Xia, Bingxue Yang, Zijun Dang, Shengli Luo, Shiyu Tang, Yuqiong Li, Qi Han, Yun Xia
We studied 34 isolates of Tigecycline-Non-Susceptible A. baumannii (TNAB) obtained from clinical specimens at a large tertiary care hospital in Chongqing, China. These 34 strains belonged to 8 different clones including ST195 (35.3%) and ST208 (17.7%). EBURST analysis found that these 8 ST types belonged to the Clonal Complex 92. Tigecycline resistance-associated genes adeR, adeS, adeL, adeN, rrf, rpsJ, and trm were detected in most strains. The expression level of the resistance-nodulation-cell division (RND) efflux pumps in TNAB strains was higher than the reference strain ATCC19606...
April 15, 2024: European Journal of Clinical Microbiology & Infectious Diseases
https://read.qxmd.com/read/38614413/emerging-threats-of-high-biofilm-formation-and-antibiotic-resistance-in-clinical-methicillin-resistant-staphylococcus-aureus-mrsa-isolates-from-pakistan
#12
JOURNAL ARTICLE
Asad Ali, Saba Riaz
OBJECTIVES: This multicenter study, conducted from a One Health perspective, aimed to comprehensively examine the prevalence of Methicillin-resistant Staphylococcus aureus (MRSA) infections and their biofilm-forming capabilities in Pakistan. Phylogenetic analysis of the study isolates was also performed. METHODS: A total of 150 MRSA isolates were screened from various clinical samples using Cefoxitin antibiotic discs. Genotypic confirmation was conducted through mecA, S...
April 11, 2024: Infection, Genetics and Evolution
https://read.qxmd.com/read/38606856/acute-liver-failure-caused-by-high-dose-tigecycline-a-case-report
#13
JOURNAL ARTICLE
Yingpei Zhang, Jiajun Wang, Yibin Tan, Jianhua Wu
High-dose tigecycline is gradually being introduced for the treatment of serious infectious diseases due to the increasing difficulty in treating pan-resistant bacterial infections. However, the safety of high-dose tigecycline is controversial. We report the case of a 76-year-old female patient with cerebral hemorrhage who received high-dose tigecycline (100 mg q12h) with other drugs for ventilator-associated pneumonia. 25 days after admission, she developed acute liver failure, mainly manifested by abnormally high bilirubin, coagulation dysfunction, and gastrointestinal hemorrhage with hemorrhagic shock...
April 12, 2024: International Journal of Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/38601741/emergence-of-eravacycline-heteroresistance-in-carbapenem-resistant-acinetobacter-baumannii-isolates-in-china
#14
JOURNAL ARTICLE
Yi-Tan Li, Xian-di Chen, Ying-Yi Guo, Shan-Wen Lin, Ming-Zhen Wang, Jian-Bo Xu, Xiao-Hu Wang, Guo-Hua He, Xi-Xi Tan, Chao Zhuo, Zhi-Wei Lin
Carbapenem-resistant Acinetobacter baumannii (CRAB) is resistant to almost all antibiotics. Eravacycline, a newer treatment option, has the potential to treat CRAB infections, however, the mechanism by which CRAB isolates develop resistance to eravacycline has yet to be clarified. This study sought to investigate the features and mechanisms of eravacycline heteroresistance among CRAB clinical isolates. A total of 287 isolates were collected in China from 2020 to 2022. The minimum inhibitory concentration (MIC) of eravacycline and other clinically available agents against A...
2024: Frontiers in Cellular and Infection Microbiology
https://read.qxmd.com/read/38601552/clinical-characteristics-and-prognosis-of-klebsiella-pneumoniae-meningitis-in-adults
#15
JOURNAL ARTICLE
Xin Yang, Yanjun Wang, Siqi Zhao, Xiaoya Huang, Bingxin Tian, Runli Yu, Qin Ding
BACKGROUND: Klebsiella pneumoniae is a causative agent of bacterial meningitis in adults. However, there is little information regarding this infection. Therefore, this study comprehensively analyzed the clinical characteristics and prognosis of Klebsiella pneumoniae meningitis (KPM) patients. METHODS: The clinical data of adult hospitalized patients with KPM were retrospectively collected from January 2015 to December 2022. The clinical characteristics and antibiotic resistance of KPM were evaluated...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38600509/characterization-of-genes-related-to-the-efflux-pump-and-porin-in-multidrug-resistant-escherichia-coli-strains-isolated-from-patients-with-covid-19-after-secondary-infection
#16
JOURNAL ARTICLE
Aryan R Ganjo, Salah Tofik Jalal Balaky, Ahang Hasan Mawlood, Sakar B Smail, Nazar P Shabila
BACKGROUND: Escherichia coli (E. coli) is a multidrug resistant opportunistic pathogen that can cause secondary bacterial infections in patients with COVID-19. This study aimed to determine the antimicrobial resistance profile of E. coli as a secondary bacterial infection in patients with COVID-19 and to assess the prevalence and characterization of genes related to efflux pumps and porin. METHODS: A total of 50 nonduplicate E. coli isolates were collected as secondary bacterial infections in COVID-19 patients...
April 10, 2024: BMC Microbiology
https://read.qxmd.com/read/38599013/evaluation-of-the-synergistic-effect-of-eravacycline-and-tigecycline-against-carbapenemase-producing-carbapenem-resistant-klebsiella-pneumoniae
#17
JOURNAL ARTICLE
Yu-Shan Huang, Jia-Ling Yang, Jann-Tay Wang, Wang-Huei Sheng, Chia-Jui Yang, Yu-Chung Chuang, Shan-Chwen Chang
BACKGROUND: Carbapenem-resistant Klebsiella pneumoniae (CRKP) poses a substantial healthcare challenge. This study assessed the in vitro efficacy of selected antibiotic combinations against CRKP infections. METHODS: Our research involved the evaluation of 40 clinical isolates of CRKP, with half expressing Klebsiella pneumoniae carbapenemase (KPC) and half producing Metallo-β-lactamase (MBL), two key enzymes contributing to carbapenem resistance. We determined the minimum inhibitory concentrations (MICs) of four antibiotics: eravacycline, tigecycline, polymyxin-B, and ceftazidime/avibactam...
March 27, 2024: Journal of Infection and Public Health
https://read.qxmd.com/read/38596009/a-systematic-review-and-meta-analysis-of-carbapenem-resistance-and-its-possible-treatment-options-with-focus-on-clinical-enterobacteriaceae-thirty-years-of-development-in-pakistan
#18
JOURNAL ARTICLE
Muhammad Umair, Timothy R Walsh, Mashkoor Mohsin
BACKGROUND: Carbapenem resistance is epidemic worldwide, these last resort antimicrobials are listed in the WHO 'watch group' with higher resistance potential. During the years 2017-18 Pakistan Antimicrobial Resistance Surveillance System reported an increase in carbapenem resistance. However, a comprehensive information on prevalence and molecular epidemiology of carbapenem resistance in Pakistan is not available. This systematic review and meta-analysis is aimed to report the current carbapenem resistance situation in Pakistan and its treatment options...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38574874/development-validation-and-clinical-application-of-a-uplc-ms-ms-method-for-omadacycline-determination-in-human-serum
#19
JOURNAL ARTICLE
Guo Suhang, Zheng Ren, Fan Xudong, Zhang Ruoying, Cai Xinjun, Jin Jie
BACKGROUND: Omadacycline is the first aminomethyl-tetracycline variety to successfully enter clinical applications. To support regular therapeutic drug monitoring (TDM) in clinical practice, an ultra-high-performance liquid chromatography coupled with tandem mass spectrometry (UPLC-MS/MS) method was developed that would allow omadacycline quantification in human serum. METHODS: Proteins were precipitated from serum samples using methanol. Tigecycline was used as the internal standard...
April 2, 2024: Journal of Pharmacological and Toxicological Methods
https://read.qxmd.com/read/38574003/tandem-amplification-of-a-plasmid-borne-tet-a-variant-gene-confers-tigecycline-resistance-in-escherichia-coli
#20
JOURNAL ARTICLE
Chenhui Zou, Chunyan Xu, Runhao Yu, Xinxin Shan, Stefan Schwarz, Dexi Li, Xiang-Dang Du
OBJECTIVES: To elucidate the mechanism of tigecycline resistance in Escherichia coli that is mediated by the tet(A) variant gene. METHODS: E. coli strain 573 carried a plasmid-borne tet(A) variant gene, tentatively designated tet(A)TIG, that conferred decreased tigecycline susceptibility (MIC 0.5 mg/L). When exposed to increasing concentrations of tigecycline (0.25-8 mg/L), mutants growing at 2, 4 and 8 mg/L were obtained and sequenced. Copies of plasmid and tet(A)TIG relative to the chromosomal DNA in the mutants were determined by WGS and quantitative PCR (qPCR)...
April 4, 2024: Journal of Antimicrobial Chemotherapy
keyword
keyword
29067
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.